E Reed

5.8k total citations
82 papers, 4.7k citations indexed

About

E Reed is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, E Reed has authored 82 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 34 papers in Molecular Biology and 15 papers in Cancer Research. Recurrent topics in E Reed's work include Cancer Treatment and Pharmacology (16 papers), DNA Repair Mechanisms (11 papers) and Prostate Cancer Treatment and Research (9 papers). E Reed is often cited by papers focused on Cancer Treatment and Pharmacology (16 papers), DNA Repair Mechanisms (11 papers) and Prostate Cancer Treatment and Research (9 papers). E Reed collaborates with scholars based in United States, Ukraine and Malaysia. E Reed's co-authors include Benjamín C. Bostick, Miriam C. Poirier, Jin‐Tai Yu, Meenakshi Dabholkar, R. J. Parker, William D. Figg, Stuart H. Yuspa, Robert F. Ozols, Gisele Sarosy and Justine Vionnet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

E Reed

81 papers receiving 4.6k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
E Reed 2.5k 2.0k 1.0k 811 722 82 4.7k
Giovanna Damia 2.7k 1.1× 1.7k 0.9× 858 0.8× 911 1.1× 396 0.5× 172 4.8k
Guido Bocci 2.4k 1.0× 2.6k 1.3× 1.2k 1.2× 1.0k 1.2× 400 0.6× 206 5.8k
W. David Henner 2.9k 1.2× 1.9k 0.9× 1.0k 1.0× 988 1.2× 853 1.2× 95 5.5k
A. Hilary Calvert 2.3k 0.9× 3.0k 1.5× 368 0.4× 1.1k 1.3× 1.1k 1.6× 75 5.9k
Francis Ali‐Osman 4.2k 1.7× 2.0k 1.0× 1.3k 1.3× 457 0.6× 571 0.8× 140 6.7k
Coby Meijer 2.0k 0.8× 2.8k 1.4× 653 0.6× 629 0.8× 353 0.5× 114 5.2k
J Carmichael 2.3k 0.9× 4.8k 2.4× 957 0.9× 1.5k 1.8× 568 0.8× 76 7.3k
M. E. Scheulen 2.3k 0.9× 2.6k 1.3× 734 0.7× 1.2k 1.4× 612 0.8× 178 5.5k
William P. Tong 3.6k 1.5× 2.1k 1.0× 641 0.6× 1.4k 1.8× 382 0.5× 110 6.6k
Renzo Canetta 894 0.4× 2.2k 1.1× 369 0.4× 502 0.6× 751 1.0× 61 3.9k

Countries citing papers authored by E Reed

Since Specialization
Citations

This map shows the geographic impact of E Reed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Reed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Reed more than expected).

Fields of papers citing papers by E Reed

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Reed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Reed. The network helps show where E Reed may publish in the future.

Co-authorship network of co-authors of E Reed

This figure shows the co-authorship network connecting the top 25 collaborators of E Reed. A scholar is included among the top collaborators of E Reed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Reed. E Reed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haider, Shozeb, et al.. (2024). 8752 The Ethical Concerns Of Improper Semaglutide Administration After Acquisition From A Compounded Pharmacy. Journal of the Endocrine Society. 8(Supplement_1).
2.
Zhao, Jinshun, et al.. (2005). Antiproliferative effect of β-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. Cellular and Molecular Life Sciences. 62(7-8). 894–904. 141 indexed citations
3.
Zhong, Xiaosong, et al.. (2003). SU5416 sensitizes ovarian cancer cells to cisplatin through inhibition of nucleotide excision repair. Cellular and Molecular Life Sciences. 60(4). 794–802. 15 indexed citations
4.
Cagnoni, P. J., Christian Brandts, Romeo A. Mandanas, et al.. (2001). Topical Transforming Growth Factor-β3 in the Prevention or Alleviation of Chemotherapy-Induced Oral Mucositis in Patients with Lymphomas or Solid Tumors. Journal of Immunotherapy. 24(4). 384–388. 41 indexed citations
5.
Molloy, Fiona, Mary Kay Floeter, Nadir Ali Syed, et al.. (2001). Thalidomide neuropathy in patients treated for metastatic prostate cancer. Muscle & Nerve. 24(8). 1050–1057. 56 indexed citations
6.
Sandor, V., E Reed, Gisele Sarosy, et al.. (1999). Synchronous inflammatory breast cancer and advanced ovarian carcinoma: A case with prolonged disease-free survival. Annals of Oncology. 10(5). 585–588. 1 indexed citations
7.
Horti, J, Shannon C. Dixon, C. Logothetis, et al.. (1999). Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitor. British Journal of Cancer. 79(9-10). 1588–1593. 23 indexed citations
8.
Figg, W D, et al.. (1999). Malignant ascites as only manifestation of metastatic prostate cancer. Prostate Cancer and Prostatic Diseases. 2(5-6). 290–293. 8 indexed citations
9.
Reed, E. (1998). Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy. Cancer Treatment Reviews. 24(5). 331–344. 324 indexed citations
10.
Dawson, Nancy A., William D. Figg, Michael R. Cooper, et al.. (1997). Phase II trial of suramin, leuprolide, and flutamide in previously untreated metastatic prostate cancer.. Journal of Clinical Oncology. 15(4). 1470–1477. 23 indexed citations
11.
Kohn, Elise C., Gisele Sarosy, Patricia Anne Davis, et al.. (1996). A Phase I/II Study of Dose-Intense Paclitaxel with Cisplatin and Cyclophosphamide as Initial Therapy of Poor-Prognosis Advanced-Stage Epithelial Ovarian Cancer. Gynecologic Oncology. 62(2). 181–191. 27 indexed citations
12.
Kohn, Elise C., Gisele Sarosy, Annette Bicher, et al.. (1994). Dose-Intense Taxol: High Response Rate in Patients With Platinum-Resistant Recurrent Ovarian Cancer. JNCI Journal of the National Cancer Institute. 86(1). 18–24. 152 indexed citations
13.
Poirier, Miriam C., et al.. (1993). Platinum drug-DNA interactions in human tissues measured by cisplatin-DNA enzyme-linked immunosorbent assay and atomic absorbance spectroscopy.. Environmental Health Perspectives. 99. 149–154. 29 indexed citations
14.
Reed, E, John E. Janik, M. A. Bookman, et al.. (1993). High-dose carboplatin and recombinant granulocyte-macrophage colony-stimulating factor in advanced-stage recurrent ovarian cancer.. Journal of Clinical Oncology. 11(11). 2118–2126. 18 indexed citations
15.
Reed, E, et al.. (1993). Inhibition of DNA Repair and Sensitization of Cisplatin in Human Ovarian Carcinoma Cells by Interleukin-1α. Biochemical and Biophysical Research Communications. 195(1). 294–300. 9 indexed citations
16.
Dabholkar, Meenakshi, Lisa Bradshaw, R. J. Parker, et al.. (1992). Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitro.. Environmental Health Perspectives. 98. 53–59. 29 indexed citations
17.
Sarosy, Gisele, Elise C. Kohn, David A. Stone, et al.. (1992). Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer.. Journal of Clinical Oncology. 10(7). 1165–1170. 163 indexed citations
18.
Parker, R. J., Alan Eastman, Benjamín C. Bostick, & E Reed. (1991). Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.. Journal of Clinical Investigation. 87(3). 772–777. 250 indexed citations
19.
Hennings, Henry, et al.. (1990). Enhanced Malignant Conversion of Benign Mouse Skin Tumors by Cisplatin. JNCI Journal of the National Cancer Institute. 82(10). 836–840. 23 indexed citations
20.
Poirier, Miriam C., E Reed, Leonard A. Zwelling, et al.. (1985). Polyclonal antibodies to quantitate cis-diamminedichloroplatinum(II)--DNA adducts in cancer patients and animal models.. Environmental Health Perspectives. 62. 89–94. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanna Damia Breakdown of academic impact, for papers by Guido Bocci Breakdown of academic impact, for papers by W. David Henner Breakdown of academic impact, for papers by A. Hilary Calvert Breakdown of academic impact, for papers by Francis Ali‐Osman Breakdown of academic impact, for papers by Coby Meijer Breakdown of academic impact, for papers by J Carmichael Breakdown of academic impact, for papers by M. E. Scheulen Breakdown of academic impact, for papers by William P. Tong Breakdown of academic impact, for papers by Renzo Canetta
Rankless by CCL
2026